ASPI Insider Filing: 447,263 Shares Sold; 1,216,000 Options Reported
Rhea-AI Filing Summary
Insider transactions by Paul Elliot Mann, CEO, director and 10% owner of ASP Isotopes Inc. (ASPI). The Form 4 reports multiple transactions on September 8-9, 2025. The filing shows sales totaling 447,263 shares disposed through Rule 10b5-1 "sell to cover" and net-share settlements at weighted-average prices reported around $8.14–$8.58. The reporting person also acquired or was issued stock/derivative awards: 216,000 and 1,000,000 employee stock options (exercise price $2) reported as acquired on 09/09/2025. Following these transactions, the reporting person beneficially owned 8,084,191 shares (direct).
The filing discloses that some dispositions were effected under a 10b5-1 trading plan adopted June 9, 2025 to cover tax withholding for vesting restricted stock and that other share withholdings satisfied option exercise obligations. No additional financial results or forward-looking statements are included.
Positive
- Insider used a Rule 10b5-1 trading plan adopted June 9, 2025 to execute planned sales, indicating pre-arranged compliance with insider-trading rules
- Acquisition of employee stock options: 216,000 and 1,000,000 options with $2 exercise price reported, showing continued compensation alignment
Negative
- Significant share dispositions: 447,263 shares were disposed (sell-to-cover and net-share settlements) on September 8-9, 2025
- Weighted-average sale prices for reported sales were in the range $8.135–$8.575, indicating insider liquidity events that increased tradable supply
Insights
TL;DR: Insider followed formal trading plan and used net settlement to satisfy tax/exercise obligations; activity is compliance-focused, not opportunistic.
The report documents structured dispositions under a Rule 10b5-1 plan adopted June 9, 2025 and share withholdings to satisfy option exercise or tax obligations. Use of a 10b5-1 plan is a governance best practice to mitigate insider trading concerns because it provides pre-specified execution terms. The mix of option grants/awards and share disposals is consistent with compensation-related liquidity events rather than open-market opportunistic selling. Materiality to shareholders is moderate given the size of beneficial ownership remaining (8,084,191 shares direct) and the absence of extraordinary transfers or pledges.
TL;DR: Significant option activity and share movements; transactions affect outstanding insider-held shares but do not disclose company operating metrics.
The filing shows acquisition of employee stock options totaling 1,216,000 options (two tranches exercisable with stated vesting/expiration dates) and contemporaneous dispositions totaling 447,263 common shares via sell-to-cover and net-settlement. These transactions change the insider's liquid share position yet leave substantial direct beneficial ownership. From a market-impact perspective, the disclosed sales were executed across price ranges noted as $8.135 to $8.575; the filing supplies a weighted-average sale price for some lots. No information on company performance or capital structure changes is provided, limiting further valuation implications.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 216,000 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 1,000,000 | $0.00 | -- |
| Exercise | Common Stock | 216,000 | $2.00 | $432K |
| Tax Withholding | Common Stock | 50,644 | $8.53 | $432K |
| Exercise | Common Stock | 1,000,000 | $2.00 | $2.00M |
| Tax Withholding | Common Stock | 234,466 | $8.53 | $2.00M |
| Sale | Common Stock | 81,077 | $8.3886 | $680K |
| Sale | Common Stock | 81,076 | $8.5279 | $691K |
Footnotes (1)
- Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.135 to $8.575, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2. Represents shares withheld by the Company in connection with net share settlement to satisfy the exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or any tax liability. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.135 to $8.575, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2. These options vested in a single installment 12 months after the grant date. The option was granted on April 4, 2022. These options vested in thirty-six equal installments beginning on the last day of month after the option's grant date. The option was granted on June 10, 2022.
